In ovarian cancer, elevated levels of HOXB-AS3 indicated an adverse prognosis 41, 44, and HOXB-AS3 overexpression is linked to higher histological grade, advanced FIGO stage, and lymph node metastasis in patients 44. This evidence concerns the gene HOXB-AS3 and metastatic malignant neoplasm in the lymph nodes.